# Enterprise Financial Services Corp: financial statements, quarterly

EFSC · Nasdaq · CIK 1025835 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efsc.md) · [Financials](/companies/efsc/financials.md) · [Filings](/companies/efsc/filings.md) · [Insiders](/companies/efsc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/efsc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [59.3](/filings/0001025835-24-000096.md) | [66.4 d](/filings/0001025835-25-000039.md) | [70.0](/filings/0001025835-25-000074.md) | [71.1](/filings/0001025835-24-000064.md) | [72.8](/filings/0001025835-24-000096.md) | [69.0 d](/filings/0001025835-25-000039.md) | [64.3](/filings/0001025835-25-000074.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [12.4](/filings/0001025835-24-000096.md) | [11.0 d](/filings/0001025835-26-000058.md) | [10.2](/filings/0001025835-25-000074.md) | [11.7](/filings/0001025835-25-000123.md) | [12.2](/filings/0001025835-25-000210.md) | [11.8 d](/filings/0001025835-26-000058.md) | [11.1](/filings/0001025835-26-000108.md) | [12.8](/filings/0001025835-26-000146.md) | [43.4](/filings/0001025835-25-000210.md) | [15.0 d](/filings/0001025835-26-000058.md) | [13.5](/filings/0001025835-26-000108.md) | [11.3](/filings/0001025835-26-000146.md) |
| Net income | $m | [44.7](/filings/0001025835-24-000096.md) | [44.5 d](/filings/0001025835-26-000058.md) | [40.4](/filings/0001025835-25-000074.md) | [45.4](/filings/0001025835-25-000123.md) | [50.6](/filings/0001025835-25-000210.md) | [48.8 d](/filings/0001025835-26-000058.md) | [50.0](/filings/0001025835-26-000108.md) | [51.4](/filings/0001025835-26-000146.md) | [45.2](/filings/0001025835-25-000210.md) | [54.8 d](/filings/0001025835-26-000058.md) | [49.4](/filings/0001025835-26-000108.md) | [40.9](/filings/0001025835-26-000146.md) |
| Diluted EPS | $ per share | [1.17](/filings/0001025835-24-000096.md) | not reported | [1.05](/filings/0001025835-25-000074.md) | [1.19](/filings/0001025835-25-000123.md) | [1.32](/filings/0001025835-25-000210.md) | not reported | [1.31](/filings/0001025835-26-000108.md) | [1.36](/filings/0001025835-26-000146.md) | [1.19](/filings/0001025835-25-000210.md) | not reported | [1.30](/filings/0001025835-26-000108.md) | [1.09](/filings/0001025835-26-000146.md) |
| Basic EPS | $ per share | [1.17](/filings/0001025835-24-000096.md) | not reported | [1.05](/filings/0001025835-25-000074.md) | [1.19](/filings/0001025835-25-000123.md) | [1.33](/filings/0001025835-25-000210.md) | not reported | [1.33](/filings/0001025835-26-000108.md) | [1.36](/filings/0001025835-26-000146.md) | [1.20](/filings/0001025835-25-000210.md) | not reported | [1.31](/filings/0001025835-26-000108.md) | [1.10](/filings/0001025835-26-000146.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [14.0](/filings/0001025835-23-000084.md) | [14.5](/filings/0001025835-25-000039.md) | [14.6](/filings/0001025835-24-000029.md) | [14.6](/filings/0001025835-24-000064.md) | [15.0](/filings/0001025835-24-000096.md) | [15.6](/filings/0001025835-26-000058.md) | [15.7](/filings/0001025835-25-000074.md) | [16.1](/filings/0001025835-25-000123.md) | [16.4](/filings/0001025835-25-000210.md) | [17.3](/filings/0001025835-26-000146.md) | [17.2](/filings/0001025835-26-000108.md) | [17.4](/filings/0001025835-26-000146.md) |
| Total liabilities | $bn | [12.4](/filings/0001025835-23-000084.md) | [12.8](/filings/0001025835-25-000039.md) | [12.9](/filings/0001025835-24-000029.md) | [12.9](/filings/0001025835-24-000064.md) | [13.1](/filings/0001025835-24-000096.md) | [13.8](/filings/0001025835-26-000058.md) | [13.8](/filings/0001025835-25-000074.md) | [14.2](/filings/0001025835-25-000123.md) | [14.4](/filings/0001025835-25-000210.md) | [15.3](/filings/0001025835-26-000146.md) | [15.2](/filings/0001025835-26-000108.md) | [15.4](/filings/0001025835-26-000146.md) |
| Shareholders' equity | $bn | [1.6](/filings/0001025835-24-000096.md) | [1.7](/filings/0001025835-26-000058.md) | [1.7](/filings/0001025835-25-000123.md) | [1.8](/filings/0001025835-25-000210.md) | [1.8](/filings/0001025835-25-000210.md) | [1.8](/filings/0001025835-26-000146.md) | [1.9](/filings/0001025835-26-000146.md) | [1.9](/filings/0001025835-26-000146.md) | [2.0](/filings/0001025835-25-000210.md) | [2.0](/filings/0001025835-26-000146.md) | [2.0](/filings/0001025835-26-000146.md) | [2.0](/filings/0001025835-26-000146.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.5 d](/filings/0001025835-24-000096.md) | [79.0 d](/filings/0001025835-26-000058.md) | [29.9](/filings/0001025835-25-000074.md) | [76.5 d](/filings/0001025835-25-000123.md) | [89.0 d](/filings/0001025835-25-000210.md) | [52.0 d](/filings/0001025835-26-000058.md) | [40.0](/filings/0001025835-26-000108.md) | [61.3 d](/filings/0001025835-26-000146.md) | [49.4 d](/filings/0001025835-25-000210.md) | [42.8 d](/filings/0001025835-26-000058.md) | [58.5](/filings/0001025835-26-000108.md) | [68.7 d](/filings/0001025835-26-000146.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001025835-24-000096.md) | [4.4 d](/filings/0001025835-26-000058.md) | [3.0](/filings/0001025835-25-000074.md) | [1.8 d](/filings/0001025835-25-000123.md) | [0.9 d](/filings/0001025835-25-000210.md) | [1.9 d](/filings/0001025835-26-000058.md) | [4.4](/filings/0001025835-26-000108.md) | [2.3 d](/filings/0001025835-26-000146.md) | [2.2 d](/filings/0001025835-25-000210.md) | [3.0 d](/filings/0001025835-26-000058.md) | [1.0](/filings/0001025835-26-000108.md) | [1.7 d](/filings/0001025835-26-000146.md) |
| Dividends paid | $m | [9.3 d](/filings/0001025835-24-000096.md) | [9.4 d](/filings/0001025835-26-000058.md) | [9.4](/filings/0001025835-25-000074.md) | [9.7 d](/filings/0001025835-25-000123.md) | [10.1 d](/filings/0001025835-25-000210.md) | [10.4 d](/filings/0001025835-26-000058.md) | [10.7](/filings/0001025835-26-000108.md) | [11.1 d](/filings/0001025835-26-000146.md) | [11.5 d](/filings/0001025835-25-000210.md) | [11.8 d](/filings/0001025835-26-000058.md) | [12.2](/filings/0001025835-26-000108.md) | [12.3 d](/filings/0001025835-26-000146.md) |
| Share repurchases | $m | [0.0 d](/filings/0001025835-24-000096.md) | [0.0 d](/filings/0001025835-26-000058.md) | [0.0](/filings/0001025835-25-000074.md) | [8.6 d](/filings/0001025835-25-000123.md) | [9.8 d](/filings/0001025835-25-000210.md) | [11.3 d](/filings/0001025835-26-000058.md) | [10.6](/filings/0001025835-26-000108.md) | [0.0 d](/filings/0001025835-26-000146.md) | [0.0 d](/filings/0001025835-25-000210.md) | [3.5 d](/filings/0001025835-26-000058.md) | [27.2](/filings/0001025835-26-000108.md) | [22.8 d](/filings/0001025835-26-000146.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.3](/filings/0001025835-23-000084.md) | [37.5](/filings/0001025835-24-000029.md) | [37.5](/filings/0001025835-24-000064.md) | [37.5](/filings/0001025835-24-000096.md) | [37.6](/filings/0001025835-25-000074.md) | [37.5](/filings/0001025835-25-000123.md) | [37.5](/filings/0001025835-25-000210.md) | [37.3](/filings/0001025835-26-000108.md) | [37.2](/filings/0001025835-26-000146.md) | [37.3](/filings/0001025835-25-000210.md) | [37.2](/filings/0001025835-26-000108.md) | [36.7](/filings/0001025835-26-000146.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,192,520 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001025835-26-000146.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.